EMA finds rare spinal condition, AZ link

AstraZeneca vial
An EMA panel says a causal relationship between AstraZeneca and transverse myelitis is possible. -AP

A safety panel of the European drug regulator has recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 vaccine.

Hold tight - we’re checking permissions before loading more content